SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-042854
Filing Date
2008-07-17
Accepted
2008-07-17 17:21:19
Documents
2
Period of Report
2008-01-31

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c73960_3.html 3  
1 MAIN DOCUMENT DESCRIPTION c73960_3.xml 3 2899
2 POWER OF ATTORNEY c73960_24.htm EX-24 4655
  Complete submission text file 0001209191-08-042854.txt   9628
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ALROV TOWER 46 ROTHSCHILD BLVD TEL AVIV L3 66883
Business Address 972-3-714-7770
Akirov Alfred (Reporting) CIK: 0001434514 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 08957776